Anaphylaxis: past, present and future
Authors:
Abstract
Anaphylaxis is a clinical emergency, and recent reports suggest increased prevalence. A diverse set of primary genetic and environmental influences may confer susceptibility to anaphylactic reactions. Anaphylaxis presents diagnostic and therapeutic challenges. It often manifests with a broad array of symptoms and signs that might be similar to other diseases. The management of anaphylaxis consists of emergency treatment of acute episodes as well as preventive strategies to avoid recurrences. Treatment is complicated by its rapid onset and progression, presence of concurrent diseases or medications, and need for long-term allergen avoidance. Health care professionals must be able to recognize the signs of anaphylaxis, treat an episode promptly and appropriately, and provide preventive recommendations. Recognizing the gaps in our understanding and management of anaphylaxis may help identify promising targets for future treatment and prevention and areas that require further study.Keywords
This publication has 135 references indexed in Scilit:
- Essential roles of sphingosine-1–phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edemaJournal of Experimental Medicine, 2010
- Combined Immunodeficiency Associated withDOCK8MutationsNew England Journal of Medicine, 2009
- Clinical efficacy and immune regulation with peanut oral immunotherapyJournal of Allergy and Clinical Immunology, 2009
- Active Plasma Kallikrein Localizes to Mast Cells and Regulates Epithelial Cell Apoptosis, Adipocyte Differentiation, and Stromal Remodeling during Mammary Gland InvolutionJournal of Biological Chemistry, 2009
- Rcan1 negatively regulates FcɛRI-mediated signaling and mast cell functionJournal of Experimental Medicine, 2009
- Prescriptions for self-injectable epinephrine and follow-up referral in emergency department patients presenting with anaphylaxisAnnals of Allergy, Asthma & Immunology, 2008
- The etiology and incidence of anaphylaxis in Rochester, Minnesota: A report from the Rochester Epidemiology ProjectJournal of Allergy and Clinical Immunology, 2008
- Mast cell–expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxisJournal of Experimental Medicine, 2008
- Report of oral clarithromycin desensitizationBritish Journal of Clinical Pharmacology, 2008
- SWAP‐70 regulates mast cell FcϵRI‐mediated signaling and anaphylaxisEuropean Journal of Immunology, 2008